How cannabinoids suppress the immune system by triggering immune cell death
A review described four pathways through which cannabinoids suppress immunity: cell death (apoptosis), proliferation inhibition, cytokine suppression, and induction of regulatory T cells.
Quick Facts
What This Study Found
The review catalogued how cannabinoids mediate immunosuppression through four broad mechanisms:
1. Apoptosis (programmed cell death) of immune cells, primarily through CB2 receptor activation
2. Inhibition of immune cell proliferation
3. Suppression of cytokine and chemokine production
4. Induction of regulatory T cells (Tregs) that dampen immune responses
CB2 receptors, predominantly expressed on immune cells, emerged as the key therapeutic target. The authors noted that cannabinoids had shown beneficial effects in models of multiple sclerosis, diabetes, septic shock, rheumatoid arthritis, and allergic asthma.
Importantly, CB2-targeted therapies could achieve immunosuppression without the psychoactive effects mediated by CB1 receptors in the brain.
Key Numbers
Four immunosuppressive pathways identified. Beneficial effects demonstrated in models of at least five autoimmune/inflammatory conditions.
How They Did This
Narrative review focusing on mechanisms of cannabinoid-induced apoptosis in immune cells, synthesizing laboratory findings on CB2 receptor-mediated immunosuppression across multiple immune cell types and disease models.
Why This Research Matters
The identification of CB2 receptor-targeted immunosuppression offered a pathway to develop anti-inflammatory therapies without the psychoactive effects of cannabis, potentially benefiting patients with autoimmune and inflammatory conditions.
The Bigger Picture
This research positioned the cannabinoid system as a potential therapeutic target for autoimmune diseases, with CB2 receptor selectivity offering a way to separate medical benefits from psychoactive effects.
What This Study Doesn't Tell Us
Primarily based on preclinical and in vitro studies. Translation to human autoimmune disease treatment remained speculative. The immunosuppressive effects could theoretically increase infection susceptibility.
Questions This Raises
- ?Can CB2-selective drugs effectively treat autoimmune diseases in humans without increasing infection risk?
- ?What is the balance between beneficial immunosuppression and harmful immune compromise?
Trust & Context
- Key Stat:
- CB2 receptor targeting could suppress immunity without psychoactive effects
- Evidence Grade:
- Comprehensive mechanistic review synthesizing substantial laboratory evidence on multiple immunosuppressive pathways.
- Study Age:
- Published in 2010. CB2-targeted drug development for autoimmune conditions has continued.
- Original Title:
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
- Published In:
- Immunobiology, 215(8), 598-605 (2010)
- Authors:
- Rieder, Sadiye Amcaoglu, Chauhan, Ashok, Singh, Ugra, Nagarkatti, Mitzi, Nagarkatti, Prakash
- Database ID:
- RTHC-00447
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Could cannabis help with autoimmune diseases?
Preclinical research showed cannabinoids suppressing immune responses through four mechanisms. CB2-selective drugs showed promise in models of MS, diabetes, arthritis, and asthma, but clinical translation was still early.
Does cannabis weaken the immune system?
Cannabinoids can suppress certain immune responses through multiple mechanisms. This immunosuppression could be harmful (increasing infection risk) or beneficial (treating autoimmune conditions where the immune system attacks the body).
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-00447APA
Rieder, Sadiye Amcaoglu; Chauhan, Ashok; Singh, Ugra; Nagarkatti, Mitzi; Nagarkatti, Prakash. (2010). Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.. Immunobiology, 215(8), 598-605. https://doi.org/10.1016/j.imbio.2009.04.001
MLA
Rieder, Sadiye Amcaoglu, et al. "Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.." Immunobiology, 2010. https://doi.org/10.1016/j.imbio.2009.04.001
RethinkTHC
RethinkTHC Research Database. "Cannabinoid-induced apoptosis in immune cells as a pathway t..." RTHC-00447. Retrieved from https://rethinkthc.com/research/rieder-2010-cannabinoidinduced-apoptosis-in-immune
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.